Clinical Trial Detail

NCT ID NCT04409002
Title Niraparib + Dostarlimab + RT in Pancreatic Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Massachusetts General Hospital
Indications

pancreatic adenocarcinoma

Therapies

Dostarlimab + Niraparib

Age Groups: adult senior

No variant requirements are available.